By G HossainPosted on September 29, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The centerpiece of the acquisition is petosemtamab, Merus’ bispecific antibody targeting EGFR and LGR5, which in May demonstrated best-in-class potential for head-and-neck cancer. Genmab Buys Rising Cancer Star Merus for $8B Post navigation FASAB clarifies accounting for government landBiogen Shuffles 20 Staff After Ending AAV Work